Document Detail


In vitro compound A formation in a computer-controlled closed-circuit anesthetic apparatus. Comparison with a classical valve circuit.
MedLine Citation:
PMID:  11020762     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Few data exist on compound A during sevoflurane anesthesia when using closed-circuit conditions and sodalime with modern computer-controlled liquid injection. METHODS: A PhysioFlex apparatus (Dräger, Lübeck, Germany) was connected to an artificial test lung (inflow approximately 160 ml/min carbon dioxide, outflow approximately 200 ml/min, simulating oxygen consumption). Ventilation was set to obtain an end-tidal carbon dioxide partial pressure (Petco2) approximately 40 mmHg. Canister inflow (T degrees in) and outflow (T degrees out) temperatures were measured. Fresh sodalime and charcoal were used. After baseline analysis, sevoflurane concentration was set at 2.1% end-tidal for 120 min. At baseline and at regular intervals thereafter, Petco2, end-tidal sevoflurane, T degrees in, and T degrees out were measured. For inspiratory and expiratory compound A determination, samples of 2-ml gas were taken. These data were compared with those of a classical valve-containing closed-circuit machine. Ten runs were performed in each set-up. RESULTS: Inspired compound A concentrations increased from undetectable to peak at 6.0 (SD 1.3) and 14.3 (SD 2.5) ppm (P < 0.05), and maximal temperature in the upper outflow part of the absorbent canister was 24.3 degrees C (SD 3.6) and 39.8 degrees C (SD 1.2) (P < 0.05) in the PhysioFlex and valve circuit machines, respectively. Differences between the two machines in compound A concentrations and absorbent canister temperature at the inflow and outflow regions were significantly different (P < 0.05) at all times after 5 min. CONCLUSION: Compound A concentrations in the high-flow (70 l/min), closed-circuit PhysioFlex machine were significantly lower than in conventional, valve-based machines during closed-circuit conditions. Lower absorbent temperatures, resulting from the high flow, appear to account for the lower compound A formation.
Authors:
L F Versichelen; G Rolly; M P Bouche; J F Van Bocxlaer; M M Struys; C Van Der Herten; A P De Leenheer; E P Mortier
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Anesthesiology     Volume:  93     ISSN:  0003-3022     ISO Abbreviation:  Anesthesiology     Publication Date:  2000 Oct 
Date Detail:
Created Date:  2000-10-13     Completed Date:  2000-10-27     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  1300217     Medline TA:  Anesthesiology     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1064-8     Citation Subset:  AIM; IM    
Affiliation:
Department of Anesthesia, Ghent University Hospital, Gent, Belgium. Linda.Versichelen@rug.ac.be
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anesthesia, Closed-Circuit* / instrumentation,  methods
Anesthetics, Inhalation / administration & dosage,  pharmacokinetics*
Carbon Dioxide / metabolism
Computers
Drug Stability
Ethers / administration & dosage,  pharmacokinetics*
Humans
Hydrocarbons, Fluorinated / administration & dosage,  pharmacokinetics*
Methyl Ethers / administration & dosage,  pharmacokinetics*
Models, Biological
Partial Pressure
Positive-Pressure Respiration
Ventilators, Mechanical
Chemical
Reg. No./Substance:
0/Anesthetics, Inhalation; 0/Ethers; 0/Hydrocarbons, Fluorinated; 0/Methyl Ethers; 124-38-9/Carbon Dioxide; 28523-86-6/sevoflurane; 58109-34-5/fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Activation of mu- and delta-opioid receptors causes presynaptic inhibition of glutamatergic excitati...
Next Document:  Disposition of bupivacaine and its metabolites in the maternal, placental, and fetal compartments in...